Predictive biomarkers of preterm delivery in women with ongoing IVF pregnancies

- Sera from IVF patients who delivered preterm or at term were evaluated.
- HE4 (p < 0.000) and IL-13 (p = 0.001) were reduced in women with a preterm birth.
- IGF-II (p = 0.023) and SLPI (p = 0.043) were increased in women with a preterm birth.
- The combination of HE4 and IL-13 were the best predictors of pregnancy outcome.

In vitro fertilization (IVF) pregnancies potentially have a higher rate of preterm delivery (PTD) than do spontaneously conceived gestations, and differences persist following adjustment for multiple gestation, maternal age, and parity. The reasons for this increased susceptibility to PTD remain incompletely elucidated. To identify potential biomarkers predictive of PTD in IVF subjects, we performed a retrospective analysis of multiple markers in sera obtained during early gestation that have been suggested to be associated with peri-implantation events. Sera from 35 women with a preterm birth and 68 women with a term delivery, obtained between 9 and 11 days after embryo transfer, were tested blindly for concentrations of interleukin (IL)-1β, IL-6, IL-13, IL-17, human epididymal protein 4 (HE4), secretory leukocyte protease inhibitor (SLPI), insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (BP)-1, and interferon-γ. Concentrations of HE4 (p = 0.001) and IL-13 (p = 0.029) were reduced, and levels of IGF-II (p = 0.023) and SLPI (p = 0.043) were increased, in women who subsequently delivered preterm. By receiver operator curve analysis, the combination of HE4 and IL-13 levels best predicted the outcome preterm birth. The association between deficiencies in circulating HE4 and IL-13 levels during early pregnancy and subsequent PTD suggest that factors contributing to sub-optimal embryo implantation influence length of gestation in women undergoing IVF.